½ÃÀ庸°í¼­
»óǰÄÚµå
1678503

¹Ì±¹ÀÇ ÀÇ·á¿ë IT ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® : ¼ÒÇÁÆ®¿þ¾î Á¾·ùº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

U.S. Healthcare IT Software Market Size, Share & Trends Analysis Report By Software Type (Revenue Cycle Management Software, Tele-healthcare Software, eClinical Software, Cloud-based EHR & EMR Software), Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 80 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¹Ì±¹ÀÇ ÀÇ·á¿ë IT ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ¼ºÀå°ú µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¹Ì±¹ÀÇ ÀÇ·á¿ë IT ¼ÒÇÁÆ®¿þ¾î ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 3,889¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2025³âºÎÅÍ 2030³â±îÁö 15.46%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÇ·áÀÇ ±Þ¼ÓÇÑ µðÁöÅÐ Àüȯ, »óÈ£¿î¿ë¼º ¹× °¡Ä¡ ±â¹Ý Áø·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÀüÀڰǰ­±â·Ï(EHR), ÀüÀÚÀǹ«±â·Ï(EMR), ¼öÀÍ Áֱ⠰ü¸®(RCM)¿Í °°Àº ¼ÒÇÁÆ®¿þ¾î ¼Ö·ç¼ÇÀÇ º¸±ÞÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾÷°è ±â¾÷µéÀº AI¿Í µ¥ÀÌÅÍ ºÐ¼®À» Ȱ¿ëÇÏ¿© °ü¸® ºÎ´ãÀ» ÁÙÀÌ°í ¼öÀÍ Ã¢ÃâÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 9¿ù Ãâ½ÃµÈ AGS HealthÀÇ AGS AI Ç÷§ÆûÀº AI¿Í ÀÚµ¿È­¸¦ Àΰ£ÀÇ Àü¹® Áö½Ä°ú ÅëÇÕÇÏ¿© RCM ¼º´ÉÀ» ÃÖÀûÈ­ÇÏ°í »ý»ê¼º ÃßÀû, ±Ùº» ¿øÀÎ ºÐ¼®, »ç¿ëÀÚ Á¤ÀÇ °¡´ÉÇÑ ´ë½Ãº¸µå¸¦ Á¦°øÇÕ´Ï´Ù.

ÀÇ·á °ø±Þ¸Á °³¼±À» À§ÇÑ ÀÇ·á°è ÁÖµµÀÇ ¿òÁ÷ÀÓ, GS1 Ç¥ÁØ ½Ã½ºÅÛ ¹× UDI(Unique Device Identification) äÅà Ȯ´ë, ¸ð¹ÙÀÏ ±â¹Ý ¹× ÀÇ·á¿ë °ø±Þ¸Á °ü¸®(SCM) ¼Ö·ç¼ÇÀÇ »ç¿ë È®´ë°¡ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ºñ¿ë Àý°¨¿¡ ´ëÇÑ ¼ö¿ä¿Í Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼ÇÀÇ µîÀåµµ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

º´¿ø, º´¸® ¹× Áø´Ü ¼¾ÅÍ, ½ÇÇè½Ç¿¡¼­ ȯÀÚ Âü¿©, ¿öÅ©ÇÃ·Î¿ì °ü¸®, û±¸, °Ç°­ Á¤º¸ ÃßÀû, ǰÁú º¸Áõ¿¡ ´ëÇÑ ÀÀ¿ëÀ¸·Î ÀÎÇØ °Ë»ç Á¤º¸ ¼ÒÇÁÆ®¿þ¾îÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 11¿ù Thermo Fisher Scientific Inc.´Â Flagship Pioneering°ú Á¦ÈÞÇÏ¿© ¿©·¯ Á¦Ç° Ç÷§ÆûÀ» °³¹ßÇÏ°í »õ·Î¿î »ý¸í°øÇÐ µµ±¸ ȸ»ç¸¦ ¼³¸³ÇÏ¿© »ý¸í°úÇÐ, Áø´Ü ¹× ¼­ºñ½º Àü¹Ý¿¡ °ÉÃÄ °ø±Þ °ü°è¸¦ È®´ëÇß½À´Ï´Ù.

Ŭ¶ó¿ìµå ±â¹Ý PACS(¿µ»ó ÀúÀå ¹× Åë½Å ½Ã½ºÅÛ) ¼Ö·ç¼ÇÀº ±âÁ¸ ¿ÂÇÁ·¹¹Ì½º ½Ã½ºÅÛ¿¡ ºñÇØ È®À强°ú ºñ¿ë È¿À²¼ºÀÌ ¶Ù¾î³ª´Ù´Â Á¡¿¡¼­ ¸¹Àº »ç¶ûÀ» ¹Þ°í ÀÖ½À´Ï´Ù. 2024³â 6¿ù, ½Å¼¼½Ã½º Çコ´Â 3°ÇÀÇ ¸ÖƼ»çÀÌÆ® °è¾àÀ» ü°áÇϸç ÀÇ·á ¿µ»ó ó¸® ºÐ¾ß¿¡¼­ ÀÔÁö¸¦ ´ÙÁö°í ÀÖ½À´Ï´Ù. Tahoe Carson Radiology(³×¹Ù´Ù), Naugatuck Valley Radiology(ÄÚ³×Æ¼ÄÆ), Intermountain Medical Imaging(¾ÆÀÌ´ÙÈ£)°úÀÇ Á¦ÈÞ¸¦ Æ÷ÇÔÇÑ ÀÌ °è¾àµéÀº ȸ»çÀÇ »ç¾÷ ¹üÀ§¸¦ È®ÀåÇϰí ÀÇ·á ½Ã¼³ Àüü¿¡¼­ ¼­ºñ½º Á¦°øÀ» Çâ»ó½Ãų °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

½ÉÀ庴, ³úÁ¹Áß°ú °°Àº ¸¸¼ºÁúȯÀÇ Áõ°¡·Î ÀÎÇØ ¿µ»óÀÇÇÐ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÅëÇÕ ÀÇ·á ½Ã½ºÅÛÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹æ»ç¼± Á¤º¸ ¼ÒÇÁÆ®¿þ¾î´Â ¿¹¾à ½ºÄÉÁÙ¸µ, ȯÀÚ ÃßÀû, °á°ú º¸°í, û±¸, ¿µ»ó °ü¸®¸¦ ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. ÀÇ·á IT, ƯÈ÷ AI/ML Áö¿ø ±â¼ú ¹× Ŭ¶ó¿ìµå ±â¹Ý ±â¼úÀÇ ¹ßÀüÀº ½ÃÀå ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 2¿ù Çʸ³½º¿Í ½Å¼¼Æ½ MRÀº ½Å°æ ÁúȯÀÇ ³ú ¿µ»ó ÃÔ¿µÀ» °­È­Çϱâ À§ÇØ ¼³°èµÈ AI ±â¹Ý ±â¼úÀÎ Smart Quant Neuro 3D¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ¼ÒÇÁÆ®¿þ¾î´Â ³ú Á¶Á÷ÀÇ ºÎÇÇ ÃøÁ¤À» ÀÚµ¿È­ÇÏ¿© ´Ù¹ß¼º °æÈ­Áõ ¹× ¿Ü»ó¼º ³ú ¼Õ»ó°ú °°Àº ÁúȯÀÇ Áø´Ü Á¤È®µµ¸¦ Çâ»ó½Ãŵ´Ï´Ù.

¹Ì±¹ÀÇ ÀÇ·á¿ë IT ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ºÐ¼® °³¿ä

  • ¼ÒÇÁÆ®¿þ¾î À¯Çüº°·Î´Â ¼öÀÍ Áֱ⠰ü¸® ¼ÒÇÁÆ®¿þ¾î ºÐ¾ß°¡ 2024³â 32.66%ÀÇ ÃÖ´ë ¸ÅÃâ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ù. RCM¿¡´Â Á¦3ÀÚ ÁöºÒ ±â°ü, ÁöºÒ ¸ðµ¨, °¡À̵å¶óÀÎ, ÄÚµå µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÇ·áÀÇ ¼º°øÀº ÀûÀýÇÑ ÀÚ»êÀ» È®º¸ÇÏ´Â µ¥ ´Þ·Á ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º ÁöºÒÀÌ º¹ÀâÇØÁü¿¡ µû¶ó È¿À²ÀûÀÎ RCM ¼Ö·ç¼ÇÀÇ °¡Ä¡´Â Á¡Á¡ ´õ Ä¿Áö°í ÀÖ½À´Ï´Ù.
  • ¿ø°ÝÀÇ·á ¼ÒÇÁÆ®¿þ¾î ºÐ¾ß´Â ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ³ôÀº ÀÎÅÍ³Ý »ç¿ë·ü°ú Ä¿³ØÆ¼µå Ȩ ¼­ºñ½ºÀÇ º¸±Þ È®´ë´Â ¿ø°ÝÀÇ·á ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÁÖ¿ä ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ, °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ºñ¿ë È¿À²ÀûÀÎ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ³ëÀÎ Àα¸ÀÇ Áõ°¡´Â ¿ø°ÝÀÇ·á ¼ÒÇÁÆ®¿þ¾î ºÐ¾ß¸¦ °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ´Ù¸¥ ÁÖ¿ä ¿äÀÎÀ¸·Î ²ÅÈü´Ï´Ù.
  • ¿¹¸¦ µé¾î, 2024³â 1¿ù GEÇコÄɾî´Â ¹æ»ç¼± Á¾¾çÇаú ¿µ»ó Áø´ÜÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ÀÇ·áÇàÀ§¸¦ À§ÇÑ ÀÇ·á ¿µ»ó ºÐ¼® ¹× AI ¼Ö·ç¼Ç Á¦°ø¾÷üÀÎ MIM¼ÒÇÁÆ®¿þ¾î¸¦ ÀμöÇϱâ·Î ÇÕÀÇÇß½À´Ï´Ù. À̹ø Àμö´Â GEÇコÄɾîÀÇ ¿µ»ó ºÐ¼® ¹× µðÁöÅÐ ¿öÅ©ÇÃ·Î¿ì ¿ª·®À» °­È­Çϱâ À§ÇÑ °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ºÐ¼® ¹æ¹ý ¹× ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ÀÇ ÀÇ·á¿ë IT ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå ¿¬°ü Àü¸Á
    • »óºÎ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ÀÇ·á¿ë IT ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ºÐ¼® Åø
    • ¾÷°è ºÐ¼® : Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®
    • COVID-19ÀÇ ¿µÇâ
    • »ç·Ê ¿¬±¸

Á¦4Àå ¹Ì±¹ÀÇ ÀÇ·á¿ë IT ¼ÒÇÁÆ®¿þ¾î ½ÃÀå : ¼ÒÇÁÆ®¿þ¾î Á¾·ùº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ½ÃÀå Á¡À¯À² : Á¾·ùº°(2024³â¡¤2030³â)
  • ºÎ¹® ´ë½Ãº¸µå
  • ¹Ì±¹ÀÇ ÀÇ·á¿ë IT ¼ÒÇÁÆ®¿þ¾î ½ÃÀå Àü¸Á : Á¾·ùº°
  • ¼öÀÍ Áֱ⠰ü¸® ¼ÒÇÁÆ®¿þ¾î
    • ¼öÀÍ Áֱ⠰ü¸® ¼ÒÇÁÆ®¿þ¾î : ½ÃÀå ÃßÁ¤°ú ¿¹Ãø(2018-2030³â)
    • ÅëÇÕÇü
    • µ¶¸³Çü
  • ¿ø°ÝÀÇ·á ¼ÒÇÁÆ®¿þ¾î
    • ¿ø°ÝÀÇ·á ¼ÒÇÁÆ®¿þ¾î : ½ÃÀå ÃßÁ¤°ú ¿¹Ãø(2018-2030³â)
    • ÅÚ·¹Äɾî
    • ÅÚ·¹Çコ
  • Áý´Ü°Ç°­°ü¸®(PHM) ¼ÒÇÁÆ®¿þ¾î
    • Áý´Ü°Ç°­°ü¸®(PHM) ¼ÒÇÁÆ®¿þ¾î : ½ÃÀå ÃßÁ¤°ú ¿¹Ãø(2018-2030³â)
  • Ŭ¶ó¿ìµå ±â¹Ý ÀüÀÚÀǹ«±â·Ï(EHR¡¤EMR) ¼ÒÇÁÆ®¿þ¾î
    • Ŭ¶ó¿ìµå ±â¹Ý ÀüÀÚÀǹ«±â·Ï(EHR¡¤EMR) ¼ÒÇÁÆ®¿þ¾î : ½ÃÀå ÃßÁ¤°ú ¿¹Ãø(2018-2030³â)
  • ÀÓ»ó Á¤º¸ ¼ÒÇÁÆ®¿þ¾î
    • ÀÓ»ó Á¤º¸ ¼ÒÇÁÆ®¿þ¾î : ½ÃÀå ÃßÁ¤°ú ¿¹Ãø(2018-2030³â)
  • ÀǷẸÇèÀÚ¿ë ±â¼ú ¼Ö·ç¼Ç ¼ÒÇÁÆ®¿þ¾î
    • ÀǷẸÇèÀÚ¿ë ±â¼ú ¼Ö·ç¼Ç ¼ÒÇÁÆ®¿þ¾î : ½ÃÀå ÃßÁ¤°ú ¿¹Ãø(2018-2030³â)
    • Ŭ·¹ÀÓ °ü¸®
    • µî·Ï°ú ȸ¿ø °ü¸®
    • ÇÁ·Î¹ÙÀÌ´õ °ü¸®
    • ¼öÀÍ °ü¸®¿Í û±¸
    • ºÐ¼®
    • °¡Ä¡¿¡ ±â¹ÝÇÑ ÁöºÒ
    • µ¥ÀÌÅÍ °ü¸®¿Í ¼­Æ÷Æ®
    • °³ÀÎÈ­/CRM
    • ÀÓ»ó ÀÇ»ç°áÁ¤ Áö¿ø
  • ÀÇ·á¿ë °í°´°ü°è°ü¸®(CRM) ¼ÒÇÁÆ®¿þ¾î
    • ÀÇ·á¿ë °í°´°ü°è°ü¸®(CRM) ¼ÒÇÁÆ®¿þ¾î : ½ÃÀå ÃßÁ¤°ú ¿¹Ãø(2018-2030³â)
    • ÆÇ¸Å
    • °í°´ ¼­ºñ½º¿Í ¼­Æ÷Æ®
    • ¸¶ÄÉÆÃ
    • µðÁöÅÐ Ä¿¸Ó½º
    • Å©·Î½º-CRM
  • ÀüÀÚÀÇ·á(eClinical) ¼ÒÇÁÆ®¿þ¾î
    • ÀüÀÚÀÇ·á ¼ÒÇÁÆ®¿þ¾î : ½ÃÀå ÃßÁ¤°ú ¿¹Ãø(2018-2030³â)
    • ÀÓ»ó½ÃÇè °ü¸® ½Ã½ºÅÛ(CTMS)
    • ÀüÀÚ ÀÓ»ó °á°ú Æò°¡(eCOA)
    • ÀüÀÚ µ¥ÀÌÅÍ ¼öÁý(EDC)¡¤CDMS
    • ÀÓ»ó µ¥ÀÌÅÍ ÅëÇÕ Ç÷§Æû
    • ÀÓ»ó ºÐ¼® Ç÷§Æû
    • ¾ÈÀü ¼Ö·ç¼Ç
    • ÀüÀÚ ÀÓ»ó½ÃÇè ¸¶½ºÅÍ ÆÄÀÏ(eTMF)
    • ·£´ýÈ­¡¤ÀÓ»ó½ÃÇè °ø±Þ °ü¸®(RTSM)
    • ÀüÀÚ µ¿ÀÇ
  • ÀÇ·á¿ë ºÐ¼® ¼ÒÇÁÆ®¿þ¾î
    • ÀÇ·á¿ë ºÐ¼® ¼ÒÇÁÆ®¿þ¾î : ½ÃÀå ÃßÁ¤°ú ¿¹Ãø(2018-2030³â)
    • ±â¼úÀû ºÐ¼®
    • Áø´Ü ºÐ¼®
    • ¿¹Ãø ºÐ¼®
    • ó¹æÀû ºÐ¼®
  • ÀÇ·á ¿µ»ó Á¤º¸ ¼ÒÇÁÆ®¿þ¾î
    • ÀÇ·á ¿µ»ó Á¤º¸ ¼ÒÇÁÆ®¿þ¾î : ½ÃÀå ÃßÁ¤°ú ¿¹Ãø(2018-2030³â)
    • ¹æ»ç¼± Á¤º¸ ¼ÒÇÁÆ®¿þ¾î
    • ¸ð´ÏÅ͸µ ºÐ¼® ¼ÒÇÁÆ®¿þ¾î
    • ÀǷ῵»óÀúÀåÀü¼Û ¼ÒÇÁÆ®¿þ¾î
  • ÀüÀÚ Ã³¹æ ¼ÒÇÁÆ®¿þ¾î(ÀüÀÚ Ã³¹æ ¼Ö·ç¼Ç)
    • ÀüÀÚ Ã³¹æ ¼ÒÇÁÆ®¿þ¾î(ÀüÀÚ Ã³¹æ ¼Ö·ç¼Ç) : ½ÃÀå ÃßÁ¤°ú ¿¹Ãø(2018-2030³â)
  • Àü»êÈ­ ÇÁ·Î¹ÙÀÌ´õ ÁÖ¹® ÀÔ·Â ¼ÒÇÁÆ®¿þ¾î
    • Àü»êÈ­ ÇÁ·Î¹ÙÀÌ´õ ÁÖ¹® ÀÔ·Â ¼ÒÇÁÆ®¿þ¾î : ½ÃÀå ÃßÁ¤°ú ¿¹Ãø(2018-2030³â)
  • °Ë»ç½Ç Á¤º¸ ¼ÒÇÁÆ®¿þ¾î
    • °Ë»ç½Ç Á¤º¸ ¼ÒÇÁÆ®¿þ¾î : ½ÃÀå ÃßÁ¤°ú ¿¹Ãø(2018-2030³â)
  • µðÁöÅÐ ÀÇ·á¿ë °ø±Þ¸Á °ü¸® ¼ÒÇÁÆ®¿þ¾î
    • µðÁöÅÐ ÀÇ·á¿ë °ø±Þ¸Á °ü¸® ¼ÒÇÁÆ®¿þ¾î : ½ÃÀå ÃßÁ¤°ú ¿¹Ãø(2018-2030³â)

Á¦5Àå °æÀï ±¸µµ

  • ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м® : ÁÖ¿ä ½ÃÀå ÁøÃâ ±â¾÷º°
  • ±â¾÷/°æÀï ºÐ·ù
  • ±â¾÷ °³¿ä/»óÀå ±â¾÷
  • ±â¾÷ ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â)
  • Àü·« ¸ÅÇÎ
    • ÁÖ¿ä ÆÇ¸Å´ë¸®Á¡ ¹× ä³Î ÆÄÆ®³Ê ¸®½ºÆ®
    • ÁÖ¿ä °í°´
    • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â)
    • Philips Healthcare
    • McKesson Corporation
    • eMDs, Inc.
    • Veradigm Inc.(formerly Allscripts Healthcare Solutions, Inc.)
    • Athenahealth, Inc.(Acquired by Hellman & Friedman and Bain Capital)
    • Carestream Health
    • GE Healthcare
    • Agfa- Gevaert Group
    • Hewlett Packard Enterprise Development LP
    • Novarad
    • Optum, Inc.
    • IBM
    • Oracle
    • SAS Institute, Inc.
    • IQVIA
    • Verisk Analytics, Inc.
    • SAP
    • Accenture
ksm 25.04.04

U.S. Healthcare IT Software Market Growth & Trends:

The U.S. healthcare IT software market size is anticipated to reach USD 388.99 billion by 2030 and is projected to grow at a CAGR of 15.46% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rapid digital transformation in healthcare, increasing demand for interoperability and value-based care, and the widespread adoption of software solutions such as Electronic Health Records (EHR), Electronic Medical Records (EMR), and Revenue Cycle Management (RCM) are driving market growth. In addition, industry players are leveraging AI and data analytics to reduce administrative burdens and enhance revenue capture. For instance, AGS Health's AGS AI Platform, launched in September 2022, integrates AI and automation with human expertise to optimize RCM performance, providing productivity tracking, root cause analysis, and customizable dashboards.

Government initiatives to improve medical supply chains, the growing adoption of GS1 standard systems and Unique Device Identification (UDI), and the increasing use of mobile-based healthcare Supply Chain Management (SCM) solutions further contribute to market expansion. In addition, the demand for cost reduction and the emergence of cloud-based solutions are key factors propelling growth.

The adoption of laboratory information software in hospitals, pathology & diagnostic centers, and research labs is rising due to its applications in patient engagement, workflow management, billing, health information tracking, and quality assurance. For instance, in November 2023, Thermo Fisher Scientific Inc. partnered with Flagship Pioneering to develop multi-product platforms, establish new biotech tool companies, and expand their supply relationship across life sciences, diagnostics, and services.

Cloud-based Picture Archiving and Communication System (PACS) solutions are gaining traction due to their scalability and cost-effectiveness compared to traditional on-premises systems. In June 2024, Synthesis Health secured three multisite contracts, enhancing its presence in the healthcare imaging sector. These contracts, including partnerships with Tahoe Carson Radiology (Nevada), Naugatuck Valley Radiology (Connecticut), and Intermountain Medical Imaging (Idaho), are expected to expand the company's reach and improve service offerings across healthcare facilities.

The rising prevalence of chronic diseases, such as heart disease and stroke, is driving the demand for radiology services, increasing the need for integrated healthcare systems. Radiology information software facilitates appointment scheduling, patient tracking, result reporting, billing, and image management. Advancements in healthcare IT, particularly AI/ML-enabled and cloud-based technologies, are further accelerating market growth. For example, in February 2024, Philips and Synthetic MR launched Smart Quant Neuro 3D, an AI-driven technology designed to enhance brain imaging for neurological disorders. This software automates brain tissue volume measurements, improving diagnostic accuracy for conditions like multiple sclerosis and traumatic brain injury.

U.S. Healthcare IT Software Market Report Highlights:

  • Based on software type, the revenue cycle management software segment led the market with the largest revenue share of 32.66% in 2024. RCM involves third-party payers, payment models, guidelines, and codes. The success of a healthcare practice depends on obtaining the right assets. As payment for medical services becomes more complex, it becomes increasingly valuable to have an efficient RCM solution.
  • The tele-healthcare software segment is expected to grow at the fastest CAGR during the forecast period. High internet usage & the growing penetration of connected home services are among the major factors expected to drive the tele-healthcare market. In addition, the increasing health consciousness, rising demand for cost-effective care, and the growing geriatric population are other key factors expected to propel the telehealth care software segment.
  • For instance, in January 2024, GE HealthCare agreed to acquire MIM Software, a provider of medical imaging analysis and AI solutions for various healthcare practices, including radiation oncology and diagnostic imaging. This acquisition aims to enhance GE HealthCare's imaging analytics and digital workflow capabilities.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Software type
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Software type outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Healthcare IT Software Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Healthcare IT Software Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
    • 3.3.3. COVID-19 Impact
    • 3.3.4. Case Study

Chapter 4. U.S. Healthcare IT Software: Software Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Healthcare IT Software by Type Outlook
  • 4.4. Revenue Cycle Management Software
    • 4.4.1. Revenue cycle management software market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.2. Integrated
      • 4.4.2.1. Integrated market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.3. Standalone
      • 4.4.3.1. Standalone market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5. Tele-healthcare software
    • 4.5.1. Tele-healthcare software market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Tele-care
      • 4.5.2.1. Tele-care market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Tele-health
      • 4.5.3.1. Tele-health market estimates and forecast 2018 to 2030 (USD Million)
  • 4.6. Population Health Management (PHM) Software
    • 4.6.1. Population health management (PHM) software market estimates and forecast 2018 to 2030 (USD Million)
  • 4.7. Cloud-based EHR & EMR Software
    • 4.7.1. Cloud-based EHR & EMR software market estimates and forecast 2018 to 2030 (USD Million)
  • 4.8. Clinical Information Software
    • 4.8.1. Clinical information software market estimates and forecast 2018 to 2030 (USD Million)
  • 4.9. Technology Solutions in the Healthcare Payers Software
    • 4.9.1. Technology solutions in the healthcare payers software market estimates and forecast 2018 to 2030 (USD Million)
    • 4.9.2. Claims Management
      • 4.9.2.1. Claims management market estimates and forecast 2018 to 2030 (USD Million)
    • 4.9.3. Enrollment and member management
      • 4.9.3.1. Enrollment and member management market estimates and forecast 2018 to 2030 (USD Million)
    • 4.9.4. Provider Management
      • 4.9.4.1. Provider management market estimates and forecast 2018 to 2030 (USD Million)
    • 4.9.5. Revenue Management and Billing
      • 4.9.5.1. Revenue management and billing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.9.6. Analytics
      • 4.9.6.1. Analytics market estimates and forecast 2018 to 2030 (USD Million)
    • 4.9.7. Value-Based Payments
      • 4.9.7.1. Value-based payments market estimates and forecast 2018 to 2030 (USD Million)
    • 4.9.8. Data Management and Support
      • 4.9.8.1. Data management and support market estimates and forecast 2018 to 2030 (USD Million)
    • 4.9.9. Personalize/CRM
      • 4.9.9.1. Personalize/CRM market estimates and forecast 2018 to 2030 (USD Million)
    • 4.9.10. Clinical Decision Support
      • 4.9.10.1. Clinical decision support market estimates and forecast 2018 to 2030 (USD Million)
  • 4.10. Healthcare Customer Relationship Management (CRM) Software
    • 4.10.1. Healthcare customer relationship management (CRM) software market estimates and forecast 2018 to 2030 (USD Million)
    • 4.10.2. Sales
      • 4.10.2.1. Sales market estimates and forecast 2018 to 2030 (USD Million)
    • 4.10.3. Customer Service and Support
      • 4.10.3.1. Customer service and support market estimates and forecast 2018 to 2030 (USD Million)
    • 4.10.4. Marketing
      • 4.10.4.1. Marketing market estimates and forecast 2018 to 2030 (USD Million)
    • 4.10.5. Digital Commerce
      • 4.10.5.1. Digital Commerce market estimates and forecast 2018 to 2030 (USD Million)
    • 4.10.6. Cross - CRM
      • 4.10.6.1. Cross - CRM market estimates and forecast 2018 to 2030 (USD Million)
  • 4.11. eClinical Software
    • 4.11.1. eClinical software market estimates and forecast 2018 to 2030 (USD Million)
    • 4.11.2. Clinical Trial Management System (CTMS)
      • 4.11.2.1. Clinical Trial Management System (CTMS) market estimates and forecast 2018 to 2030 (USD Million)
    • 4.11.3. Electronic Clinical Outcome Assessment (eCOA)
      • 4.11.3.1. Electronic Clinical Outcome Assessment (eCOA) market estimates and forecast 2018 to 2030 (USD Million)
    • 4.11.4. Electronic Data Capture (EDC) & CDMS
      • 4.11.4.1. Electronic Data Capture (EDC) & CDMS market estimates and forecast 2018 to 2030 (USD Million)
    • 4.11.5. Clinical Data Integration Platforms
      • 4.11.5.1. Clinical Data Integration Platforms market estimates and forecast 2018 to 2030 (USD Million)
    • 4.11.6. Clinical Analytics Platforms
      • 4.11.6.1. Clinical Analytics Platforms market estimates and forecast 2018 to 2030 (USD Million)
    • 4.11.7. Safety Solutions
      • 4.11.7.1. Safety Solutions market estimates and forecast 2018 to 2030 (USD Million)
    • 4.11.8. Electronic Trial Master File (eTMF)
      • 4.11.8.1. Electronic Trial Master File (eTMF) market estimates and forecast 2018 to 2030 (USD Million)
    • 4.11.9. Randomization and Trial Supply Management (RTSM)
      • 4.11.9.1. Randomization and Trial Supply Management (RTSM) market estimates and forecast 2018 to 2030 (USD Million)
    • 4.11.10. eConsent
      • 4.11.10.1. eConsent market estimates and forecast 2018 to 2030 (USD Million)
  • 4.12. Healthcare Analytics Software
    • 4.12.1. Healthcare analytics software market estimates and forecast 2018 to 2030 (USD Million)
    • 4.12.2. Descriptive Analytics
      • 4.12.2.1. Descriptive Analytics market estimates and forecast 2018 to 2030 (USD Million)
    • 4.12.3. Diagnostic Analytics
      • 4.12.3.1. Diagnostic Analytics market estimates and forecast 2018 to 2030 (USD Million)
    • 4.12.4. Predictive Analytics
      • 4.12.4.1. Predictive Analytics market estimates and forecast 2018 to 2030 (USD Million)
    • 4.12.5. Prescriptive Analytics
      • 4.12.5.1. Prescriptive Analytics market estimates and forecast 2018 to 2030 (USD Million)
  • 4.13. Medical Imaging Information Software
    • 4.13.1. Medical imaging information software market estimates and forecast 2018 to 2030 (USD Million)
    • 4.13.2. Radiology Information Software
      • 4.13.2.1. Radiology information software market estimates and forecast 2018 to 2030 (USD Million)
    • 4.13.3. Monitoring Analysis Software
      • 4.13.3.1. Monitoring Analysis Software market estimates and forecast 2018 to 2030 (USD Million)
    • 4.13.4. Picture Archiving and Communication Software
      • 4.13.4.1. Picture Archiving and Communication Software market estimates and forecast 2018 to 2030 (USD Million)
  • 4.14. Electronic Prescribing Software (E-Prescribing Solutions)
    • 4.14.1. Electronic prescribing software (e-prescribing solutions) market estimates and forecast 2018 to 2030 (USD Million)
  • 4.15. Computerized Provider Order Entry Software
    • 4.15.1. Computerized provider order entry software market estimates and forecast 2018 to 2030 (USD Million)
  • 4.16. Laboratory Information Software
    • 4.16.1. Laboratory information software market estimates and forecast 2018 to 2030 (USD Million)
  • 4.17. Digital Healthcare Supply Chain Management Software
    • 4.17.1. Digital healthcare supply chain management software Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Competitive Landscape

  • 5.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 5.2. Company/Competition Categorization
  • 5.3. Company Profiles/Listing
  • 5.4. Company Market Share Analysis, 2024
  • 5.5. Strategy Mapping
    • 5.5.1. List of key distributors and channel partners
    • 5.5.2. Key customers
    • 5.5.3. Key company market share analysis, 2024
    • 5.5.4. Philips Healthcare
      • 5.5.4.1. Company overview
      • 5.5.4.2. Financial performance
      • 5.5.4.3. Technology Type benchmarking
      • 5.5.4.4. Strategic initiatives
    • 5.5.5. McKesson Corporation
      • 5.5.5.1. Company overview
      • 5.5.5.2. Financial performance
      • 5.5.5.3. Technology Type benchmarking
      • 5.5.5.4. Strategic initiatives
    • 5.5.6. eMDs, Inc.
      • 5.5.6.1. Company overview
      • 5.5.6.2. Financial performance
      • 5.5.6.3. Technology Type benchmarking
      • 5.5.6.4. Strategic initiatives
    • 5.5.7. Veradigm Inc. (formerly Allscripts Healthcare Solutions, Inc.)
      • 5.5.7.1. Company overview
      • 5.5.7.2. Financial performance
      • 5.5.7.3. Technology Type benchmarking
      • 5.5.7.4. Strategic initiatives
    • 5.5.8. Athenahealth, Inc. (Acquired by Hellman & Friedman and Bain Capital)
      • 5.5.8.1. Company overview
      • 5.5.8.2. Financial performance
      • 5.5.8.3. Technology Type benchmarking
      • 5.5.8.4. Strategic initiatives
    • 5.5.9. Carestream Health
      • 5.5.9.1. Company overview
      • 5.5.9.2. Financial performance
      • 5.5.9.3. Technology Type benchmarking
      • 5.5.9.4. Strategic initiatives
    • 5.5.10. GE Healthcare
      • 5.5.10.1. Company overview
      • 5.5.10.2. Financial performance
      • 5.5.10.3. Technology Type benchmarking
      • 5.5.10.4. Strategic initiatives
    • 5.5.11. Agfa- Gevaert Group
      • 5.5.11.1. Company overview
      • 5.5.11.2. Financial performance
      • 5.5.11.3. Technology Type benchmarking
      • 5.5.11.4. Strategic initiatives
    • 5.5.12. Hewlett Packard Enterprise Development LP
      • 5.5.12.1. Company overview
      • 5.5.12.2. Financial performance
      • 5.5.12.3. Technology Type benchmarking
      • 5.5.12.4. Strategic initiatives
    • 5.5.13. Novarad
      • 5.5.13.1. Company overview
      • 5.5.13.2. Financial performance
      • 5.5.13.3. Technology Type benchmarking
      • 5.5.13.4. Strategic initiatives
    • 5.5.14. Optum, Inc.
      • 5.5.14.1. Company overview
      • 5.5.14.2. Financial performance
      • 5.5.14.3. Technology Type benchmarking
      • 5.5.14.4. Strategic initiatives
    • 5.5.15. IBM
      • 5.5.15.1. Company overview
      • 5.5.15.2. Financial performance
      • 5.5.15.3. Technology Type benchmarking
      • 5.5.15.4. Strategic initiatives
    • 5.5.16. Oracle
      • 5.5.16.1. Company overview
      • 5.5.16.2. Financial performance
      • 5.5.16.3. Technology Type benchmarking
      • 5.5.16.4. Strategic initiatives
    • 5.5.17. SAS Institute, Inc.
      • 5.5.17.1. Company overview
      • 5.5.17.2. Financial performance
      • 5.5.17.3. Technology Type benchmarking
      • 5.5.17.4. Strategic initiatives
    • 5.5.18. IQVIA
      • 5.5.18.1. Company overview
      • 5.5.18.2. Financial performance
      • 5.5.18.3. Technology Type benchmarking
      • 5.5.18.4. Strategic initiatives
    • 5.5.19. Verisk Analytics, Inc.
      • 5.5.19.1. Company overview
      • 5.5.19.2. Financial performance
      • 5.5.19.3. Technology Type benchmarking
      • 5.5.19.4. Strategic initiatives
    • 5.5.20. SAP
      • 5.5.20.1. Company overview
      • 5.5.20.2. Financial performance
      • 5.5.20.3. Technology Type benchmarking
      • 5.5.20.4. Strategic initiatives
    • 5.5.21. Accenture
      • 5.5.21.1. Company overview
      • 5.5.21.2. Financial performance
      • 5.5.21.3. Technology Type benchmarking
      • 5.5.21.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦